These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26361417)

  • 1. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
    Chen DH; Yu JW; Jiang BJ
    World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis.
    Gu Y; Li T; Kapoor A; Major P; Tang D
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32752094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contactin 1 as a potential biomarker promotes cell proliferation and invasion in thyroid cancer.
    Shi K; Xu D; Yang C; Wang L; Pan W; Zheng C; Fan L
    Int J Clin Exp Pathol; 2015; 8(10):12473-81. PubMed ID: 26722434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
    Zhao J; Yang C; Guo S; Wu Y
    Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.
    Yan J; Ojo D; Kapoor A; Lin X; Pinthus JH; Aziz T; Bismar TA; Wei F; Wong N; De Melo J; Cutz JC; Major P; Wood G; Peng H; Tang D
    Cancer Res; 2016 Mar; 76(6):1603-14. PubMed ID: 26795349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in gastric cancer: The cutting-edge.
    Yuan LW; Yamashita H; Seto Y
    World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Contactin 1 in Cancers: What We Know So Far.
    Liang Y; Ma C; Li F; Nie G; Zhang H
    Front Oncol; 2020; 10():574208. PubMed ID: 33194679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Contactin 1 promotes growth, migration and invasion in Hs578T breast cancer cells.
    Chen N; He S; Geng J; Song ZJ; Han PH; Qin J; Zhao Z; Song YC; Wang HX; Dang CX
    BMC Cell Biol; 2018 Apr; 19(1):5. PubMed ID: 29673312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.
    Yashiro M; Matsuoka T
    World J Gastroenterol; 2016 Feb; 22(8):2415-23. PubMed ID: 26937130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of advanced gastric cancer: the role of new molecular drugs.
    De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
    World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Companion diagnostics for the targeted therapy of gastric cancer.
    Yoo C; Park YS
    World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive biomarkers along gastric cancer pathogenetic pathways.
    Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R
    Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel CD9-targeted therapies in gastric cancer.
    Murayama Y; Oritani K; Tsutsui S
    World J Gastroenterol; 2015 Mar; 21(11):3206-13. PubMed ID: 25805926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
    Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
    World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
    Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
    Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
    Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.